GSK has added the European Medicines Agency to the list of regulatory bodies that have approved Blenrep (belantamab mafodotin) for multiple myeloma, following the UK, Japan, Switzerland, Canada, and ...
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. Chart does not reflect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback